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Albumin restores lysophosphatidylcholine-induced inhibition Oxidized low-density lipoprotein (ox-LDL) impairs en-
of vasodilation in the rat aorta. dothelium-dependent relaxation (EDR) [1]. One change
Background. Impairment of vasodilation by oxidized low- observed in ox-LDL is the marked increase in lysophos-density lipoprotein has been attributed to lysophosphatidylcho-
phatidylcholine (LPC) content [2, 3]. LPC has been im-line (LPC). Albumin avidly binds LPC. Therefore, hypoalbum-
inemia may directly impair vasodilation and thus contribute plicated as the factor that is primarily responsible for
to increased risk of atherosclerosis in nephrotic syndrome. The disturbed EDR [2, 3], even at very low concentrations
addition of albumin reduces LPC in erythrocytes and endothe- (0.1 to 10 mol/L) [4]. A characteristic of LPC is that itlial cells. We hypothesized that the addition of albumin will sal-
is reversibly bound to albumin [5, 6], erythrocytes [7],vage vasodilation in aortic rings previously exposed to LPC.
or lipoproteins [3, 8] in the circulation. Albumin servesLPC increases superoxide production and disturbs l-arginine
availability. Therefore, we also decreased superoxide with a like a reservoir for LPC, effectively controlling LPC bio-
superoxide dismutase mimic, MnCl2, and supplemented l-argi- availability. Recently, we showed that the LPC concen-
nine in an attempt to restore vasodilation.
tration was increased in very LDL (VLDL) and LDLMethods. Rat aorta rings, which had been incubated with var-
fractions of normolipidemic patients with hypoalbumi-ious concentrations of LPC and human serum albumin (HSA),
were mounted in organ chambers. Relaxation was studied with nemia, although the sum of LPC in all plasma fractions
acetylcholine (0.01 to 100 mol/L) after precontraction with was normal [9]. Furthermore, Stoll, Oskarsson, and Spec-
phenylephrine (CON, 0.3 mol/L; LPC, 0.03 mol/L). In some tor have shown that albumin reduces LPC uptake instudies MnCl2 or l-arginine was added to the organ chamber.
cultured endothelial cells and erythrocytes [10]. The LPCResults. LPC had time- and dose-dependent inhibitory ef-
fects on acetylcholine-mediated vasodilation, but no effect on content was increased in erythrocytes from analbumi-
nitroprusside-mediated vasodilation. Preincubation with albu- nemic rats, which was normalized by the addition of
min (50 or 6 g/L) could protect vasodilation against very high albumin [11]. The addition of albumin to ox-LDL also
levels of LPC. After preincubation with LPC, the addition of
decreases LPC content in the membrane of culturedalbumin to the incubation salvaged vasodilation. Albumin was
endothelial cells [12].more effective after short LPC incubation. MnCl2 had no spe-
cific effect on the LPC-mediated disturbance in vasodilation. Impairment in EDR caused by LPC is probably due
l-arginine completely salvaged vasodilation at low concentra- to derangement of endothelium membrane structure be-
tions of LPC. However, even high concentrations of l-arginine
cause of transfer of LPC from ox-LDL to this compart-(1 mmol/L) could not improve vasodilation at LPC levels at
ment [13, 14]. This derangement in membrane structurewhich vasodilation was restored by albumin.
Conclusions. LPC affects several pathways that inhibit vaso- can be responsible for the disturbance of several path-
dilation, all of which are salvaged by addition of albumin. ways affected by LPC. One of these pathways is the
capability of LPC to increase superoxide production via
activation of kinases. LPC can stimulate superoxide pro-
duction in isolated human neutrophils and vascular
smooth muscle cells by activating phosphatidylinositol 3
kinase [15] and protein kinase C [16], respectively. An-Key words: l-arginine, endothelium-dependent relaxation, superoxide,
oxidized low-density lipoprotein, nephrotic syndrome, aortic rings. other mechanism by which LPC can disturb EDR is by
inhibiting the high-affinity component of the arginine
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activation of nitric oxide synthase (NOS) because of the with indomethacin (10 mol/L) to prevent the formation
of endogenous prostaglandins. Relaxation with acetyl-derangement in endothelial membrane structure [18–20].
It was found that EDR was disturbed in patients [21] choline (0.01, 1, and 100 mol/L) and sodium nitroprus-
side (separate dose-response curves and 10 mol/L atand in rats [22] with the nephrotic syndrome, where both
hypoalbuminemia and hyperlipidemia were present. Fur- the end of each acetylcholine experiment) was examined
during precontraction with phenylephrine (0.3 mol/Lthermore, it was found that l-arginine could restore im-
paired EDR in patients with combined hyperlipidemia for control rings and 0.03 mol/L for rings treated with
LPC). At least three rats and three rings per rat were[23] and familial hypercholesterolemia [24, 25]. However,
it is remarkable that l-arginine could not correct the im- used in each condition. Note that HSA was present only
during the incubation period, but not in the organ cham-pairment of EDR in the nephrotic syndrome [21]. This
may be due to hypoalbuminemia over and above hyper- ber. Foam formation did not occur because the buffer was
gassed with 95% O2 /5% CO2 before the incubation periodcholesterolemia, and implies that besides high cholesterol
levels, hypoalbuminemia also may induce a specific intra- and in the organ chamber after the incubation period.
The first experiment consisted of aortic rings exposedendothelial derangement. We hypothesized that hypo-
albuminemia will result in diminished binding of LPC to to LPC for 90 minutes at different concentrations (0 to
100mol/L) followed by contraction with phenylephrinealbumin and hence sequestration of LPC in endothelial
cells, which will directly impair EDR by one or more of (PE). In the second experiment, rings were exposed to
LPC for 90 minutes at different concentrations (0 tothe mechanisms mentioned previously in this article.
Therefore, we tested whether albumin can protect en- 200 mol/L) and preconstricted with PE, and the dose-
response to sodium nitroprusside was measured. In thedothelial cells against the deleterious effects of LPC and
whether the addition of albumin will salvage EDR in rat third experiment, the rings were exposed to LPC for 30
or 90 minutes at different concentrations (0 to 200mol/L)aortic rings previously exposed to LPC. LPC concentra-
tions used were similar to those found in total plasma and preconstricted with PE, and the dose-response to
acetylcholine was measured. In the fourth experiment,and LDL in nephrotic subjects [9]. We also investigated
the pathways by which LPC can disturb EDR, by testing the rings were preincubated with LPC (100 mol/L) for
different incubation times (0, 5, 10, 20, 30, 60, or 90 min).whether addition of l-arginine or of MnCl2, a superoxide
dismutase mimic [26], could salvage EDR. The fifth experiment consisted of preincubation with
50, 20, or 6 g/L HSA for 90 minutes. To display the
capability of HSA to protect EDR by preventing uptake
METHODS
of LPC, we added LPC (0 to 2000 mol/L) to the HAS
Organ chamber experiments solution after 30 minutes. In the sixth experiment, we
wanted to demonstrate the ability of albumin to salvageMale Sprague-Dawley rats weighing 200 to 250 g were
housed in a controlled environment and given free access LPC-induced impairment in EDR by binding of LPC
that already had been taken up into the tissue. Rings wereto standard rat chow and tap water. All animal proce-
dures were approved by our university animal care and preincubated with LPC, for 30 or 90 minutes, followed
by the addition of 50 g/L HSA after 10 or 30 minutes,use committee.
Aortas were dissected free during anesthesia with phe- respectively.
In the seventh and eighth experiments, rings exposednobarbital sodium (60 mg/kg IP) and immersed in a car-
bogenized Krebs-Ringer buffer composed of (in mmol/L) to LPC, but not incubated with albumin, were tested with
MnCl2 (dismutation of superoxide) or l-arginine (increas-118.3 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2,
25.0 NaHCO3, and 11.1 glucose. The aortas were care- ing NO availability), respectively. Twenty minutes before
the addition of PE to the rings, MnCl2 or l-argininefully cleaned of blood clots and peri-aortic tissue and
were cut into rings (2 to 4 mm long). Care was taken was added to the organ chambers. At the end of every
experiment, the integrity of smooth muscle dilatory func-not to damage the endothelium. The rings were mounted
horizontally between two stainless steel hooks in organ tion was checked with sodium nitroprusside (10mol/L).
chambers filled with 10 mL of Krebs-Ringer buffer
Lucigenin-enhanced chemiluminescence(37C) gassed with 95% O2 /5% CO2. One hook was
anchored in the organ chamber, and the other was con- Superoxide activity was measured using a LUMAT
LB 9507 (Berthold, Wildbad, Germany) luminometer.nected to a strain gauge transducer for the measurement
of isometric tension. The aortic rings were then progres- In vitro enzymatic systems that produced little O2 have
shown that lucigenin itself can act as a source of O2 viasively stretched to an optimal basal tension of 1 g, and
the contraction ability of the rings was checked with KCl. auto-oxidation of the lucigenin cation radical [27]. Dose-
response curves with lucigenin were obtained (3, 10, 100,Rings were incubated with Krebs-Ringer buffer in the
presence or absence of human serum albumin (HSA) and 300 mol/L) in rat aorta to find a concentration of
lucigenin at which auto-oxidation does not occur [28].and/or LPC. In the organ chamber, all rings were treated
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Fig. 1. Dose-response curves to phenylephrine (PE) were determined after 90-minute incubations with 0 (), 60 (), 100 ()mol/L lysophosphati-
dylcholine (LPC) or 50 g/L human serum albumin (HSA; ). HSA did not affect contraction to PE, while rings incubated with LPC were more
sensitive. (Inset) Dose-response curves to sodium nitroprusside (SNP) were determined after 90-minute incubations with 0 (), 60 (), 100 (),
and 200 () mol/L lysophosphatidylcholine (LPC). LPC did not affect relaxation to SNP.
This was 100 mol/L. Rat aorta rings (1 cm long) were
Table 1. Effect of lysophosphatidylcholine (LPC) on acetylcholineincubated, in Krebs-Ringer buffer, for 90 minutes with
(1 mol/L)-mediated relaxation after phenylephrine contraction:or without LPC at room temperature. After incubation,
Concentration-dependent effects at 30- and 90-minute incubations
the rings were put in a polystyrene tube (Sarstedt, Nu¨m-
Incubationbrecht, Germany) with 300 L Krebs-HEPES buffer
Concentration 30 min 90 mincomposed of (in mmol/L) 10 HEPES, 135.3 NaCl, 4.7
KCl, 1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, and 11.1 glucose. 0 mol/L LPC 629 654
10 mol/L LPC ND 4315bThe tube was placed in the luminometer, and back-
20 mol/L LPC ND 517bground lucigenin-enhanced chemiluminescence (LEC)
40 mol/L LPC 4512a 357b
was measured for four minutes. Lucigenin (bis-N-methyl 60 mol/L LPC 436a 52b
80 mol/L LPC 113a 22bacridinium nitrate, 300 L) was injected, realizing a final
100 mol/L LPC 92a 11bconcentration of 100 mol/L, and LEC was measured
200 mol/L LPC 52a 00b
during 10 minutes (sample rate 1 Hz). Finally, MnCl2
Data are expressed as percentage relaxation. ND is not determined.
was injected to reverse the superoxide production, and aP  0.05 vs. 0 mol/L LPC (incubation 30 min)
bP  0.05 vs. 0 mol/L LPC (incubation 90 min)LEC was measured for two minutes. Rings were dried
overnight and weighed. LEC was calculated as average
counts measured during the last five minutes minus aver-
age background activity and was expressed as counts per
10 mg dry weight [29]. Table 2. Time-dependent effects of 100 mol/L
lysophosphatidylcholine (LPC)
Agents
Time 100 mol/L LPC
L--lysophosphatidylcholine, containing primarily pal-
0 min 654
mitic (C16:0) and stearic (C18:0) acids, phenylephrine, ace- 5 min 597
10 min 205atylcholine, KCl, sodium nitroprusside, l-arginine, MnCl2,
20 min 52aindomethacin, and lucigenin were obtained from Sigma
30 min 92a
Chemical Co. (St. Louis, MO, USA). HSA was obtained 60 min 22a
90 min 11afrom the Central Laboratory Blood bank (CLB; Amster-
aP  0.05 vs. 0 mindam, The Netherlands). All drugs were dissolved and
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Table 3. Effect of human serum albumin (HSA) on Acetylcholine-mediated relaxation
lysophosphatidylcholine (LPC)-mediated inhibition
of acetylcholine (1 mol/L)-mediated relaxation after Relaxation to ACh was determined after incubation
phenylephrine contraction, after a 90-minute incubation period of the rings with LPC for 30 or 90 minutes. Relaxation
to sodium nitroprusside was complete at all LPC levelsHSA
after either short or long incubation. Dose-response curves50 g/L LPC 20 g/L 6 g/L 0 g/L
were obtained (data not shown), and the data were com-0 mol/L LPC 616 685 625 654
pared at an ACh concentration of 1 mol/L. Increasing100 mol/L LPC 641 638 626 11d
200 mol/L LPC 554 634 444c 00d concentrations of LPC had an increasing inhibitory effect
400 mol/L LPC 593 605 72c ND on EDR, which was more pronounced after a longer600 mol/L LPC 586 547 11c ND
incubation time (Table 1). LPC-induced impairment in800 mol/L LPC 242a 54b ND ND
1000 mol/L LPC 236a 00b 00c ND EDR was also time dependent. When rings were incu-
1400 mol/L LPC 144a ND ND ND bated with 100 mol/L LPC, the concentration found in2000 mol/L LPC 149a 00b ND ND
LDL fractions of normolipidemic patients with hypo-
Data are expressed as percentage relaxation. ND is not determined.
albuminemia [9], during a 10- to 90-minute incubationaP  0.05 vs. 0 mol/L LPC (50 g/L HSA)
bP  0.05 vs. 0 mol/L LPC (20 g/L HSA) time, the EDR was progressively impaired (Table 2).cP  0.05 vs. 0 mol/L LPC (6 g/L HSA)
Rings incubated in buffer with the vehicle (methanoldP  0.05 vs. 0 mol/L LPC (0 g/L HSA)
2.44%) showed normal EDR.
Protection by albumin against LPC effect
diluted in saline (0.9% NaCl), except LPC and indometh- To test the hypothesis that albumin could bind LPC
acin, which were dissolved in methanol (maximum final and therefore prevent its uptake into the endothelium,
concentration 2.44%), and KCl, which was dissolved in preincubation with 50 g/L HSA, as a model for normo-
demineralized water. albuminemia, was done for 90 minutes. After 30 minutes,
LPC was added. HSA alone did not affect EDR com-
Data analysis pared with controls. Higher LPC levels were needed to
Results are expressed as mean  SEM. The PE dose– block EDR than without HSA (Table 3). HSA (50 g/L)
response is expressed in gram contraction. In rings precon- completely protected EDR up to 600 mol/L LPC. Par-
tracted with PE, acetylcholine responses are expressed as tial protection was present at 1 mmol/L, and slight pro-
percent relaxation. One-way (LPC concentration, incu- tection was even seen at 2 mmol/L. On the other hand,
bation time) or two-way (LPC concentration  incuba- after preincubation with 20, 6, and 0 g/L HSA, as a model
tion time, LPC concentration  arginine or MnCl2 con- for mild and severe hypoalbuminemia and analbumi-
centration) analysis of variance was used to evaluate nemia, respectively, progressively less LPC, as compared
the statistical significance between values obtained in with 50 g/L HSA, was needed to disturb EDR (Table 3).
different groups. Values were considered statistically dif- These results show that albumin was very effective in
ferent at P  0.05. binding LPC and preventing LPC-induced impairment
in EDR.
RESULTS Salvaging EDR with albumin after exposure to LPC
Phenylephrine and nitroprusside dose–response Next, we studied whether 50 g/L albumin could scav-
The PE dose–response was determined in control rat enge LPC that was already present in the tissue. Rings
aortic rings and rings incubated with LPC for 90 minutes. were incubated with LPC (100 mol/L) for 30 or 90 min-
A low LPC concentration (20 mol/L) had no effects utes. Albumin was added at 10 or 30 minutes, respectively.
on the PE response (data not shown). However, at higher HSA (50 g/L) restored ACh-mediated relaxation com-
LPC levels (60 and 100 mol/L), the rings were more pletely in the short incubation and to 25% in the long
sensitive to PE, and the maximum contraction was in- incubation (P  0.05 vs. LPC alone; Fig. 2). Thus, albu-
creased (Fig. 1A). Therefore, different PE concentra- min could salvage LPC-induced impairment in EDR by
tions—0.3 mol/L for controls and 0.03 mol/L for rings binding to both LPC in the solution and to LPC that
incubated with LPC—were used for relaxation studies presumably had already been taken up in the tissue.
with acetylcholine (ACh). Precontraction obtained at
Superoxide production increased by LPC did notthese PE concentrations was approximately 70% of the
impair EDRmaximum contraction. SNP dose response was deter-
mined in control rings and in rings incubated with LPC Lysophosphatidylcholine dose-dependently increased
(60 to 200 mol/L) for 90 minutes. Even at 200 mol/L, superoxide production, measured with LEC (Fig. 3, inset).
Superoxide activity was abolished after addition of MnCl2LPC did not affect the SNP response (Fig. 1B).
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Fig. 2. Both 30- and 90-minute incubations
with 100 mol/L LPC blocked acetylcholine
(1mol/L)-mediated relaxation, and later, the
addition of human serum albumin (HSA; 50 g/L)
after 10 and 30 minutes, respectively, com-
pletely restored relaxation in the short incuba-
tion and partially restored relaxation in the long
incubation. *P  0.05 vs. control; #P  0.05
vs. LPC.
(100mol/L). However, although MnCl2 always increased centration. After a shorter incubation with LPC, EDR
was less disturbed, and 50 g/L HSA completely salvagedEDR approximately 10%, it had no specific effect on the
EDR. l-arginine could only completely restore EDRdose-dependent LPC-mediated disturbance (Fig. 3).
impairment when caused by a low concentration of LPC
L-arginine restored EDR after exposure to LPC (20 mol/L), while the superoxide dismutase-mimic
MnCl2 had no specific effect on the LPC-mediated im-l-arginine did not affect the vascular function of CON
pairment in EDR.rings; however, l-arginine (10mol/L; Fig. 4) completely
Lysophosphatidylcholine content is increased in ox-LDLrestored the disturbance in EDR induced by 20 mol/L
as compared with native LDL [2, 3]. LPC is also avidlyLPC, and also dose-dependently restored EDR after 40
bound by albumin. Albumin can stimulate the releasemol/L LPC. Complete restoration of EDR was seen by
of LPC from cultured rat hepatocytes [30], and a loss ofthe addition of 1 mmol/L l-arginine to rings exposed to 40
albumin binding of LPC may affect membrane-linkedmol/L LPC. However, 1 mmol/L l-arginine only partially
cell function by deranging membrane structures [13, 14].restored EDR after 60 mol/L LPC. In contrast to albu-
Such changes in the membrane could influence the func-min, not even the highest concentration of l-arginine
tion of membrane-bound receptors [18] and, therefore,could improve EDR at LPC levels higher than 60 mol/L.
vascular function by disrupting signal transduction [19, 20].
Bradykinin-induced EDR in porcine coronary arteries
DISCUSSION is dose-dependently inhibited by low concentrations of
The present study shows that acetylcholine mediated LPC (0 to 20 mol/L) [31]. In the latter study, albumin
endothelium-dependent relaxation (EDR), which was was used to bind LPC to prevent damage to the endothe-
dose- and time-dependently blocked after incubation with lial cells [31]. However, organ chamber studies to find
LPC, could be protected and salvaged by a physiological out whether the addition of albumin can salvage EDR
concentration of HSA. In fact, preincubation with 50 g/L in vascular tissue previously exposed to LPC have not
HSA completely protected EDR against LPC levels that yet been done. The results of the present study show that
were sixfold higher than those found in LDL of nephrotic albumin could both protect EDR against the inhibitory
subjects [9]. However, preincubation with 6 g/L HSA only effect of LPC and salvage EDR after exposure to LPC,
presumably by preventing the uptake of LPC or by ex-partially protected EDR against a much lower LPC con-
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Fig. 3. The superoxide dismutase-mimic, MnCl2 (100 mol/L), consistently increased acetylcholine (ACh; 1 mol/L)-mediated relaxation, but had no
specific effects on the lysophosphatidylcholine (LPC)-mediated disturbance. Symbols are: () no MnCl2; ( ) 100 mol/L MnCl2; *P 0.05 vs. 0 mol/L
LPC without MnCl2;P 0.05 vs. 0 mol/L LPC with MnCl2; #P 0.05 MnCl2 vs. no MnCl2 at each LPC concentration. (Inset) LPC dose-dependently
increased superoxide activity, measured with LEC.
tracting LPC, respectively. After a long (90 min) incuba- dation of NO [37], whereas hypoalbuminemia results in
tion period with LPC, albumin was not able to restore diminished binding of LPC to albumin and sequestration
EDR fully. Whether this has implications for hypoalbu- of LPC in lipoproteins and possibly in other compart-
minemia in vivo cannot be determined from these experi- ments. Indeed, high LPC levels in VLDL, intermediate
ments. density lipoprotein (IDL), and LDL were related to hy-
In human plasma, albumin is the most abundant pro- poalbuminemia rather than to hyperlipidemia in a se-
tein with a normal concentration of approximately 40 g/L lected group of normolipidemic nephrotic patients with
[32]. It is well known that a rapid exchange of LPC occurs severe hypoalbuminemia. Moreover, in hyperlipidemic
between red cell membranes and either albumin [33, 34] nephrotic subjects, LPC levels in lipoproteins were even
or lipoproteins [35]. Furthermore, it has been shown higher [9].
that albumin can reduce the uptake of LPC by cultured
Cell membranes have a high affinity for LPC [30]. Sev-
endothelial cells [10]. Thus, it is conceivable that in the
eral pathways are described by which LPC can exert itspresence of a normal or increased production of LPC
effect on the endothelium. One of these pathways is theduring hypoalbuminemia, endothelial function will be
activation of kinases, resulting in superoxide anion pro-disturbed. Previously we found that red blood cells from
duction [15, 16, 38]. The present study confirms thatanalbuminemic rats showed a marked increase in LPC
superoxide activity, measured with LEC, is increased incontent with a concomitant reduction in deformability.
rat aortic rings incubated with LPC. The increase ofThese changes were reversed by the addition of albumin
superoxide activity could be reversed with MnCl2, a su-[11]. Hypoalbuminemia and hyperlipidemia that usually
peroxide dismutase mimic [26]. However, MnCl2 couldoccur in conjunction in the nephrotic syndrome can both
not restore LPC-mediated impairment in EDR. Thisdisturb endothelial function. Hyperlipidemia may increase
superoxide production [36], resulting in enhanced degra- shows that LPC-induced superoxide activity, in as far as
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Fig. 4. At low concentrations of LPC (	40
mol/L), L-arginine (L-arg) completely restored
acetylcholine (1 mol/L)-mediated relaxation.
At higher concentrations of LPC (
60mol/L),
even large amounts of l-arg could not affect full
restoration. Symbols are: ( ) no l-arg; ( ) 10
mol/L l-arg; ( ) 100 mol/L l-arg; ( ) 1000
mol/L l-arg; *P  0.05 vs. 0 mol/L LPC
without l-arg; P  0.05 vs. 0 mol/L LPC
with l-arg; #P 0.05 l-arg vs. no l-arg at each
LPC concentration.
this can be assessed by the antioxidant effect of MnCl2, tients with combined hyperlipidemia [23] or familial hy-
percholesterolemia [24, 25]. However, we found that onlyis not responsible for the impairment in EDR.
Albumin has been identified as an antioxidant [39, 40], very high concentrations of l-arginine could partially
restore EDR at 60 mol/L LPC, and no restoration waspossibly due to binding of transition metals [32, 39, 40],
LPC, or both. If albumin is an antioxidant, then SOD- seen at 100 mol/L. Note that this was not due to an
effect on vascular smooth muscle function because nitro-mimics should salvage LPC-mediated EDR impairment.
Although we found that LPC dose-dependently in- prusside-mediated vasodilation was normal. A concen-
tration of 100 mol/L is close to the LPC concentrationcreased superoxide production and that MnCl2 abolished
LPC-mediated superoxide production, MnCl2 could not found in LDL fractions in plasma of nephrotic syndrome
patients [9]. Previously, we failed to restore EDR withrestore ACh-mediated relaxation after exposure to LPC.
Therefore, we assume that albumin had other effects l-arginine in nephrotic syndrome patients, at a dose that
did restore EDR in normoalbuminemic hypercholester-than merely scavenging superoxide anions.
Another pathway by which LPC could impair EDR olemic subjects [23, 24]. This suggests that, although LPC
reduces the availability of l-arginine for nitric oxide syn-is via inhibition of the high-affinity component of the
arginine transporter by LPC [17], resulting in an impaired thase (NOS), this is not the only LPC-effect that inhibits
EDR.NO production. Our results show that l-arginine can dose-
dependently restore LPC-mediated disturbance in EDR. In conclusion, in the absence of albumin, LPC levels
that occur in normal plasma completely block EDR.At low concentrations of LPC (	40 mol/L), complete
restoration was seen. This is analogous with the finding Albumin can protect EDR against even higher LPC con-
centrations and can salvage EDR after exposure to LPCthat l-arginine restores EDR in normoalbuminemic pa-
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nemia causes high blood viscosity by increasing red cell lysophos-levels that occur in circulating LDL of nephrotic subjects.
phatidylcholine. Kidney Int 52:761–770, 1997Albumin could restore EDR at high concentrations of 12. Kugiyama K, Kerns SA, Morrisett JD, et al: Impairment of endo-
LPC at which l-arginine had no effect. At low LPC con- thelium-dependent arterial relaxation by lysolecithin in modified
low-density lipoproteins. Nature 344:160–162, 1990centrations, the restoration of l-arginine transport appears
13. Leung SW, Teoh H, Quan A, et al: Endothelial dysfunction exacer-to produce enough NO for complete recovery of EDR. bates the impairment of relaxation by lysophosphatidylcholine in
Albumin was more effective than l-arginine because it porcine coronary artery. Clin Exp Pharmacol Physiol 24:984–986,
1997probably reduced the primary effect, that is, uptake of
14. Gudi S, Nolan JP, Frangos JA: Modulation of GTPase activityLPC into the cell membrane. Thus, LPC affects several
of G proteins by fluid shear stress and phospholipid composition.
pathways that inhibit EDR, all of which are salvaged by Proc Natl Acad Sci USA 95:2515–2519, 1998
15. Nishioka H, Horiuchi H, Arai H, et al: Lysophosphatidylcholineaddition of albumin.
generates superoxide anions through activation of phosphatidyl-
inositol 3-kinase in human neutrophils. FEBS Letters 441:63–66,
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